Published in Ann Rheum Dis on April 01, 1981
Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med (1978) 1.94
Familial thrombosis due to antithrombin 3 deficiency. Blood (1974) 1.73
Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.52
The stimulation of globin synthesis by heme. Proc Natl Acad Sci U S A (1966) 1.86
Rubella infection of synovial cells and the resistance of cells derived from patients with rheumatoid arthritis. J Exp Med (1970) 1.48
Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45
Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med (1989) 1.43
Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol (1979) 1.39
Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol (1981) 1.32
Structure and function of the synovial membrane. Bull Rheum Dis (1966) 1.29
Localization of hyaluronic acid in synovial cells by radioautography. J Cell Biol (1968) 1.26
THE RENAL EXCRETION OF URIC ACID IN GOUT. J Clin Invest (1962) 1.23
Pericardial tamponade in systemic lupus erythematosus; with absent hemolytic complement activity in pericardial fluid. N Y State J Med (1975) 1.14
Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol (1982) 1.14
A cytotoxic proteinase isolated from human lymphocytes. J Immunol (1978) 1.05
Characterization and partial purification of dihydroxyacetone kinase in Dunaliella salina. Biochim Biophys Acta (1980) 1.05
Simultaneous gout, pseudogout, and septic arthritis. Arthritis Rheum (1980) 1.02
Uridine incorporation into the media and RNA of cultured rheumatoid synovial cells. Arthritis Rheum (1973) 1.01
The role of heme in the synthesis and assembly of hemoglobin. J Biol Chem (1968) 1.01
The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med (1978) 1.01
Bioluminometric assay of ADP and ATP at high ATP/ADP ratios: assay of ADP after enzymatic removal of ATP. Anal Biochem (1993) 1.01
Articular complications of meningococcal meningitis. An immune complex disorder. Arch Intern Med (1980) 1.01
The isolation of the membrane of the toad bladder epithelial cell. J Cell Biol (1966) 1.00
Protease activity of normal and PHA stimulated human lymphocytes. Cell Immunol (1975) 0.99
Immunofluorescent studies of human articular cartilage. Ann Rheum Dis (1966) 0.99
Nitrogen mustard: an "in vitro" inhibitor of erythrocyte sickling. Biochem Biophys Res Commun (1972) 0.99
[NMR studies of glycerol permeability in lipid vesicles, erythrocytes and the alga Dunaliella]. Biochim Biophys Acta (1982) 0.98
Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med (1982) 0.96
Regulation of cellular energy metabolism: the Crabtree effect. Biochim Biophys Acta (1980) 0.95
Growth and morphological transformations of Helicobacter pylori in broth media. J Clin Microbiol (1997) 0.95
Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J Clin Invest (1992) 0.95
Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum (2001) 0.93
Effects of inhibitors of protein synthesis on the synthesis of heme in rabbit reticulocytes. Biochem Biophys Res Commun (1967) 0.92
Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody. J Clin Invest (1987) 0.92
Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity. J Rheumatol (1999) 0.89
A new rapid method for the isolation of surface membranes from tissue culture cells. J Cell Biol (1970) 0.89
A factor promoting the initiation of globin synthesis in a rabbit reticulocyte cell-free system. Proc Natl Acad Sci U S A (1969) 0.89
Studies of surface membranes of two mouse fibroblast cell lines. Biochim Biophys Acta (1972) 0.89
Interactions of extractable nuclear antigen (ENA) and double stranded DNA. Arthritis Rheum (1974) 0.88
The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol (1986) 0.87
The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med (1983) 0.87
Possible relationships between an infectious agent and the immune reactions of rheumatoid synovitis. Am J Med (1973) 0.86
Clinical significance of immune deposits in the skin in SLE. Arthritis Rheum (1977) 0.86
Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus. Neurology (1979) 0.86
Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol (1984) 0.86
A consensus conference on complex biologics and low molecular weight heparins. Int Angiol (2010) 0.86
Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol (1997) 0.85
Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement. J Rheumatol (1980) 0.85
Fibromyalgia syndrome and serotonin. Clin Exp Rheumatol (2001) 0.84
The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study. Am J Med (1981) 0.84
Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis. J Rheumatol (1987) 0.84
Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum (2000) 0.84
Chronic polyarthritis associated with hypogammaglobulinemia. A study of two patients. Arthritis Rheum (1977) 0.84
Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. J Rheumatol (1984) 0.83
Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients. Arthritis Rheum (1981) 0.83
Central nervous system systemic lupus erythematosus versus central nervous system infection: low cerebral spinal fluid glucose and pleocytosis in a patient with a prolonged course. Arthritis Rheum (1982) 0.82
Endothelin stimulates Na(+)-K(+)-ATPase activity by a protein kinase C-dependent pathway in rabbit aorta. Am J Physiol (1991) 0.82
Antibodies to dAT detected by membrane filtration. Arthritis Rheum (1976) 0.82
Chronic gonococcal arthritis. J Rheumatol (1989) 0.81
Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum (1980) 0.81
The control of hemoglobin synthesis. Trans Assoc Am Physicians (1967) 0.81
Pancreatitis and systemic lupus erythematosus: a case report. Arthritis Rheum (1983) 0.79
Sensorineural hearing loss in conjunction with aortic insufficiency in systemic lupus erythematosus. Scand J Rheumatol (2001) 0.79
Natural killer cell activity of mononuclear cells from rheumatoid patients measured by a conjugate-binding cytotoxicity assay. Arthritis Rheum (1982) 0.79
Glucose is required to maintain ATP/ADP ratio of isolated bovine cerebral microvessels. Am J Physiol (1990) 0.79
Soluble interleukin-2 receptor levels in lupus nephritis. Clin Nephrol (1992) 0.78
Characterization of a BALB/c 3T3 preadipose cell mutant with altered Na+K+Cl- cotransport activity. J Cell Physiol (1985) 0.78
Psychologically distinguishable groups of rheumatoid arthritis patients: a controlled, single blind study. Psychosom Med (1982) 0.78
The growth of vaccine strains of rubella virus in cultured human synovial cells. Proc Soc Exp Biol Med (1971) 0.78
Combined autoimmune disease in a patient with AIDS. Clin Rheumatol (2002) 0.78
The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci (1977) 0.77
Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus. J Clin Pathol (1983) 0.77
A distinct coagulopathy associated with interleukin-2 therapy. Br J Haematol (1994) 0.77
Effects of hypoglycemia and diabetes on fuel metabolism by rat brain microvessels. Am J Physiol (1988) 0.77
The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Arthritis Rheum (1985) 0.77
The immunoglobulin class of anti-DNA antibodies: detection by a fluorometric immunoassay: clinical and pathological correlations in SLE. J Rheumatol (1978) 0.76
Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus. Am J Med (1989) 0.76
Therapeutic intensive plasmapheresis. Semin Hematol (1981) 0.75
Antiperinuclear factor and antikeratin antibody in the diagnosis of rheumatoid arthritis: comment on the article by Kim and Weisman. Arthritis Rheum (2000) 0.75
Triad of glomerulonephritis, antinuclear antibodies, and positive skin immunofluorescence. Variant of systemic lupus erythematosus. Am J Med (1983) 0.75
Potassium cyanate, an in vitro inhibitor of lymphocyte blast transformation without in vivo activity. Proc Soc Exp Biol Med (1976) 0.75
Laboratory criteria for a diagnosis of systemic lupus erythematosus. JAMA (1979) 0.75
Blood-group-A-like substances in pneumococcal vaccine. Ann Intern Med (1982) 0.75
Vasculitis; associated with renal oncocytoma. N Y State J Med (1981) 0.75
Leukocytoclastic vasculitis in an intravenous heroin abuser. N Y State J Med (1983) 0.75
Activation of cyclophosphamide by liver cell cultures. Biochem Pharmacol (1975) 0.75
Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion. Am J Clin Pathol (1977) 0.75
A lupus antibody syndrome associated with hypernephroma. Arthritis Rheum (1979) 0.75
Bilateral total knee replacement in a patient with sickle cell disease. Clin Orthop Relat Res (1974) 0.75